These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 24586534)

  • 1. Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A; Stadler J; Montgomery E; Hartmann M; Magazi B; Mathebula F; Schwartz K; Laborde N; Soto-Torres L
    PLoS One; 2014; 9(2):e89118. PubMed ID: 24586534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
    AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A; Stadler J; Luecke E; Laborde N; Hartmann M; Montgomery ET;
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19146. PubMed ID: 25224610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
    Luecke EH; Cheng H; Woeber K; Nakyanzi T; Mudekunye-Mahaka IC; van der Straten A;
    J Int AIDS Soc; 2016; 19(1):20875. PubMed ID: 27247202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences on visit retention in clinical trials: insights from qualitative research during the VOICE trial in Johannesburg, South Africa.
    Magazi B; Stadler J; Delany-Moretlwe S; Montgomery E; Mathebula F; Hartmann M; van der Straten A
    BMC Womens Health; 2014 Jul; 14():88. PubMed ID: 25065834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence.
    Katz AWK; Mensch BS; Woeber K; Musara P; Etima J; van der Straten A
    BMC Womens Health; 2019 Jan; 19(1):18. PubMed ID: 30683103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR; Wallace M; Bekker LG; Roux S; Atujuna M; Sebastian E; Dye BJ; Elharrar V; Grant RM
    AIDS Behav; 2017 May; 21(5):1361-1375. PubMed ID: 27317411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa.
    Hartmann M; Palanee-Phillips T; O'Rourke S; Adewumi K; Tenza S; Mathebula F; Wagner D; Ayub A; Montgomery ET
    AIDS Care; 2019 Jun; 31(6):660-666. PubMed ID: 30309246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study.
    van der Straten A; Ryan JH; Reddy K; Etima J; Taulo F; Mutero P; Taylor J; Piper J; Musara P;
    J Int AIDS Soc; 2020 Jun; 23(6):e25536. PubMed ID: 32524700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sharing of Investigational Drug Among Participants in the Voice Trial.
    Moodley J; Naidoo S; Moodley J; Ramjee G
    AIDS Behav; 2016 Nov; 20(11):2709-2714. PubMed ID: 27146827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
    J Acquir Immune Defic Syndr; 2020 Dec; 85(4):458-465. PubMed ID: 33136745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidden harms: women's narratives of intimate partner violence in a microbicide trial, South Africa.
    Stadler J; Delany-Moretlwe S; Palanee T; Rees H
    Soc Sci Med; 2014 Jun; 110():49-55. PubMed ID: 24721447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
    de Vos L; Mudzingwa EK; Fynn L; Atujuna M; Mugore M; Gandhi M; Celum C; Hosek S; Bekker LG; Daniels J; Medina-Marino A
    J Int AIDS Soc; 2023 Sep; 26(9):e26175. PubMed ID: 37758649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negotiating the use of female-initiated HIV prevention methods in a context of gender-based violence: the narrative of rape.
    Hartmann M; Montgomery E; Stadler J; Laborde N; Magazi B; Mathebula F; van der Straten A
    Cult Health Sex; 2016; 18(6):611-24. PubMed ID: 26551920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's perceptions and experiences of HIV prevention trials in Soweto, South Africa.
    Stadler JJ; Delany S; Mntambo M
    Soc Sci Med; 2008 Jan; 66(1):189-200. PubMed ID: 17904718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PrEP reminds me that I am the one to take responsibility of my life: a qualitative study exploring experiences of and attitudes towards pre-exposure prophylaxis use by women in Eswatini.
    Bjertrup PJ; Mmema N; Dlamini V; Ciglenecki I; Mpala Q; Matse S; Kerschberger B; Wringe A
    BMC Public Health; 2021 Apr; 21(1):727. PubMed ID: 33853575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
    Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
    J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Killing two birds with one stone" - a qualitative study on women's perspectives on the dual prevention pill in Johannesburg, South Africa.
    Tenza S; Mampuru L; Moji M; Zulu S; Begg L; Bruce IV; Reddy K; Friedland BA; Palanee-Phillips T; Mathur S
    BMC Womens Health; 2024 Aug; 24(1):462. PubMed ID: 39174929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "It Was Not My Aim to Sleep There": The Impact of Timing and Location of Sex on Adherence to Coitally-Dependent HIV Pre-exposure Prophylaxis.
    Scorgie F; Stadler J; Baron D; Ju S; Ikaneng T; Mabude Z; Makgopa S; Malefo MA; Manenzhe KN; Mazibuko T; Ntjana H; Nkala B; Palanee-Phillips T; Gray G; Rees H; Delany-Moretlwe S
    AIDS Behav; 2018 Nov; 22(11):3692-3704. PubMed ID: 29909589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivering PrEP to Young Women in a Low-Income Setting in South Africa: Lessons for Providing Both Convenience and Support.
    Cassidy T; Ntuli N; Kilani C; Malabi N; Rorwana B; Mutseyekwa T; O'Connell R; Steele SJ; Ndlovu Z; Ellman T; de Azevedo V; Pfaff C; Nelson A; Duran LT
    AIDS Behav; 2022 Jan; 26(1):147-159. PubMed ID: 34259963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.